「red」の検索結果

Extract structured knowledge from source material. Comprehensive extraction is the default — every insight that serves the domain gets extracted. For domain-relevant sources, skip rate must be below 10%. Zero extraction from a domain-relevant source is a BUG. Triggers on "/reduce", "/reduce [file]", "extract insights", "mine this", "process this".

日本語の概要は準備中です。原文の説明を表示しています。

Install, configure, and start FireRed-OpenStoryline from source on a local machine. Use when a user asks to set up OpenStoryline, troubleshoot installation, download required resources, fill config.toml API keys, or launch the MCP and web services, as well as Chinese requests like “安装 OpenStoryline”, “配置 OpenStoryline”, “启动 OpenStoryline”, “把 OpenStoryline 跑起来”, “修复 OpenStoryline 安装问题”, or “排查 OpenStoryline 启动失败”.

日本語の概要は準備中です。原文の説明を表示しています。

Read the user's local TradingView desktop app through opencli: quotes, options chains with greeks and per-strike IV, options expiries, screener results across stocks, crypto, forex, futures, and bonds, gainers and losers, news headlines and full stories, alerts (active, fired, offline fires), watchlists including colored flag lists, symbol search, chart state, and chart screenshots. Use this skill whenever the user asks for any of these from TradingView ("TV") — for example an options chain, puts, or IV skew for a ticker, an oversold-stock screen, their red flag list, which alerts fired, or a screenshot of their chart. For plain quotes, TA readouts, scans, or futures without the desktop app, prefer tradingview-mcp. Read-only: it never places trades or edits watchlists, alerts, or layouts.

日本語の概要は準備中です。原文の説明を表示しています。

Handle paired-end FASTQ files (R1/R2) using Biopython. Use when working with Illumina paired reads, synchronizing pairs, interleaving/deinterleaving, or filtering paired data.

日本語の概要は準備中です。原文の説明を表示しています。

Predict B-cell and T-cell epitopes using BepiPred, IEDB tools, and structure-based methods for vaccine and antibody design. Identify immunogenic regions in antigens. Use when designing vaccines, mapping antibody binding sites, or predicting immunogenic peptides.

日本語の概要は準備中です。原文の説明を表示しています。

AWS Startups reference content — Activate FAQ, credits guide, programs, partner offers, sample architectures, and hundreds of learn articles spanning generative AI, cloud architecture, cost optimization, security, fundraising, go-to-market, and real-world startup case studies. Use when the user asks factual questions about AWS Activate (eligibility, credits, programs, providers), wants a sample architecture or solution guide, or needs an AWS-curated learn article on a specific startup topic. For copy-paste AI prompts (RAG chatbot, MVP scaffold, security baseline, GPU quota, etc.), see the prompt-library-for-startups skill. Do not use for: account-specific lookups (credits balance, Activate membership status, application status), real-time event listings beyond the events stub, or content not present in the bundled `references/` tree.

日本語の概要は準備中です。原文の説明を表示しています。

Startup-tailored AWS architecture advice for non-agent workloads, adjusted to the company's stage (pre-revenue through Series B+), team size, runway, and credits. Not for AI agents: deploying an AI agent on AWS, picking its runtime, or any agentic architecture is agent-advisor. Use when a founder wants guidance or a recommendation rather than code changes: which services to choose, how to plan or review an architecture, how to stretch credits and control cost, or how to prepare architecture for a fundraise or technical diligence. For an interactive discovery flow that scaffolds and writes the architecture into the codebase, use start-building-for-startups. Do not use for: writing or scaffolding code, factual AWS Activate / programs / credits lookups (see knowledge-base-for-startups), a single copy-paste prompt (see prompt-library-for-startups), or migration intent such as GCP-to-AWS, Azure-to-AWS, or Heroku-to-AWS (see the migration skills: `gcp-to-aws`, `azure-to-aws`, `heroku-to-aws`, `llm-to-bedrock`).

日本語の概要は準備中です。原文の説明を表示しています。

Generates complete cross-disease shared-biomarker bioinformatics research designs from a user-provided disease pair and validation direction. Always use this skill whenever a user wants to design, plan, or build a multi-dataset study linking two related diseases through shared DEGs, enrichment, PPI hub genes, public validation, regulatory-network analysis, immune infiltration, drug-gene interaction screening, and optional qRT-PCR or cell-line validation. Covers five study patterns (shared-DEG discovery, hub-gene prioritization, regulatory-network interpretation, immune/drug follow-up, bioinformatics-plus-validation) and always outputs four workload configs (Lite / Standard / Advanced / Publication+) with recommended primary plan, step-by-step workflow, figure plan, validation strategy, minimal executable version, publication upgrade path, and a strictly verified reference literature retrieval layer with real references only.

日本語の概要は準備中です。原文の説明を表示しています。

Generates complete reference-grounded single-drug adverse-effect network-pharmacology research designs from a user-provided drug, adverse event, and desired evidence depth. Always use this skill when a user wants to design, plan, or upgrade a conventional network-pharmacology study centered on one fixed drug and one fixed adverse-effect endpoint, using drug-target prediction, adverse-event target collection, overlap analysis, PPI hub prioritization, enrichment interpretation, molecular docking, and optional orthogonal transcriptomic or literature validation. Covers five study patterns (canonical hub-first, cardiotoxicity or electrophysiology-oriented, immune-inflammatory adverse effect, organ-toxicity pathway context, translational validation) and always outputs four workload configs (Lite / Standard / Advanced / Publication+) with a recommended primary plan, dependency/evidence map, step-by-step workflow, figure plan, validation strategy, minimal executable version, publication upgrade path, verified-reference pack, and self-critical risk review.

日本語の概要は準備中です。原文の説明を表示しています。

Draft a structured preregistration document (OSF, AsPredicted, or AEA RCT Registry style) from a research spec or free-form study description. Output is a Markdown file with hypotheses, design, sampling plan, analysis plan, exclusions, and inference criteria — annotated with MUST / SHOULD / MAY clarity flags. Use when user says "preregister", "draft a preregistration", "OSF preregistration", "AsPredicted", "AEA RCT registry", "PAP", "preanalysis plan", or before launching an experiment / data collection / analysis on data the analyst has not yet seen. NOT a registry submission tool — produces a document the user uploads to OSF / AsPredicted / AEA themselves.

日本語の概要は準備中です。原文の説明を表示しています。

Create or revise Chinese social-media covers through the registered Skill-封面 asset system, reusable styles, presenter identities, ratio-specific layouts, and exact replacement prompts. Use only when the user explicitly says“skill-cover”“Skill-封面”“实战风格”, requests the registered style/gesture assets, asks for simultaneous 3:4 and 4:3 registered-layout output, replaces a reference cover's person with the current digital-human frame, or extends this registered cover system. Do not use for a generic“制作封面/生成封面”request; generic cover requests belong to dog-skill.

日本語の概要は準備中です。原文の説明を表示しています。

Map an organisation's risks against its insurance policy portfolio to find what's uncovered, underinsured, or double-covered. Use when asked to run a coverage gap analysis, review an insurance programme against a risk register, check what risks aren't insured, or audit a policy portfolio. Produces a risk-by-coverage matrix, flagged gaps and overlaps, a deductible stack review, and recommendations ranked by expected-loss severity.

日本語の概要は準備中です。原文の説明を表示しています。

Researches Reddit using a brand's Brand DNA to find promotable pain-point discussions, target subreddits, and real user search language. Produces a prioritized Reddit opportunity list for content seeding, helpful replies, and prompt research inspiration.

日本語の概要は準備中です。原文の説明を表示しています。

Identify tumor neoantigens from somatic variants with pVACtools (pVACseq/pVACfuse/pVACbind/pVACvector/pVACview) for personalized cancer vaccines and checkpoint biomarkers. Encodes the field's hard truth that binding prediction is the easy, near-solved part and single-digit-percent PPV lives downstream — so it centers clonality/CCF, HLA LOH (the silent invalidator), expression, proximal-variant phasing, agretopicity/foreignness quality, and the predicted->presented->immunogenic validation tiers. Use when nominating vaccine targets, ranking neoantigens, or building a tumor-to-candidate pipeline. Binding details in mhc-binding-prediction; ranking in immunogenicity-scoring.

日本語の概要は準備中です。原文の説明を表示しています。

Build enhancer-driven gene regulatory networks (eGRNs) by integrating single-cell RNA-seq and ATAC-seq using SCENIC+, CellOracle base GRNs, Pando, FigR, DIRECT-NET, TRIPOD, and scMEGA. Covers the accessibility-defines-enhancers principle, peak-to-gene linking and its cell-composition confound, the paired-vs-unpaired decision, and TF-region-gene eRegulon triplets. Use when analyzing 10x multiome or paired/unpaired scRNA+scATAC to infer cis-regulatory GRNs. For RNA-only regulons see scenic-regulons; for in silico TF perturbation see perturbation-simulation.

日本語の概要は準備中です。原文の説明を表示しています。

Predicts ADMET properties using ADMETlab 3.0 (119 platform features, including 77 prediction models with modeled-endpoint uncertainty), ADMET-AI, DeepChem MolNet, and chemprop D-MPNN with explicit handling of OECD QSAR principles, applicability domain assessment, calibration, hERG/CYP/AMES endpoints, and PAINS / Lipinski / Ro5 / Veber / BBB druglikeness filters. Use when filtering compounds for drug-likeness, prioritizing leads by predicted safety, or building an in-house ADMET QSAR model.

日本語の概要は準備中です。原文の説明を表示しています。

Performs gene-level association from GWAS summary statistics via genetically predicted tissue expression using FUSION, PrediXcan, S-PrediXcan, S-MultiXcan, UTMOST, MOSTWAS, kTWAS, EpiXcan, TIGAR-V2, and probabilistic fine-mapping with FOCUS and MA-FOCUS. Use when running TWAS from GWAS sumstats, prioritising candidate causal genes from a GWAS lead locus, picking single-tissue vs cross-tissue models, identifying LD-induced TWAS false positives, choosing ancestry-matched prediction weights, fine-mapping co-regulated TWAS hits, or triangulating TWAS with cis-eQTL Mendelian randomization and colocalization to nominate a causal gene.

日本語の概要は準備中です。原文の説明を表示しています。

When the user wants to add or optimize structured data (Schema.org, JSON-LD). Also use when the user mentions "schema," "structured data," "JSON-LD," "rich results," "rich snippets," "Google rich snippets," "featured snippet schema," "add schema to page," "missing structured data," "schema validation error," "Schema Markup Validator," "Google Rich Results Test," "FAQ schema," "Article schema," "Organization schema," "JobPosting," "HowTo," "Event," "SoftwareApplication," "BreadcrumbList," "WebSite," "Recipe," "Product," or "Dataset." For SERP feature types and zero-click patterns, use serp-features. For AI search visibility strategy (not markup), use generative-engine-optimization. For HowTo step sections (placement, copy, vs FAQ), use howto-section-generator.

日本語の概要は準備中です。原文の説明を表示しています。

Running closed and open betas that produce real signal. Beta participant selection, structured feedback collection, beta-to-GA decision criteria, and the difference between soft-launch (no structure, no signal), kitchen-sink (everyone in, no actionable feedback), and structured beta (calibrated cohort, intentional feedback loops, clear graduation criteria). Triggers on beta program, alpha test, beta cohort, beta participant, beta feedback, beta to GA decision, design partner, early access program, closed beta, open beta, RC release. Also triggers when a feature is approaching launch and the team needs structured pre-GA validation, when prior betas produced noise rather than signal, or when the team has soft-launched before but wants more structured feedback this time.

日本語の概要は準備中です。原文の説明を表示しています。

Critically assess and improve a legal scholarly thesis, article idea, student note, seminar-paper claim, or research agenda using Eugene Volokh's novelty, nonobviousness, utility, and soundness framework, connector-aware research, claim-specific tests, and a sustainable adversarial pass. Produces a self-contained green-, yellow-, or red-light report. Use when a law professor or law student asks whether a claim is viable, novel, publishable, preempted, useful, worth pursuing, or better than competing topics; or wants a thesis stress-tested, narrowed, repaired, or compared. No connector is required: use connected legal and scholarly research when available, public sources otherwise, and disclose any no-research fallback.

日本語の概要は準備中です。原文の説明を表示しています。

Redesign a classroom as a prepared environment optimised for independent learning, calm transitions, and material access. Use when classroom layout hinders independence or self-directed work.

日本語の概要は準備中です。原文の説明を表示しています。

Create and publish social media posts for Reddit, Twitter/X, LinkedIn, Instagram, Facebook, and TikTok. Platform-specific formats, character limits, hashtag strategies, hooks, and content repurposing. Can post directly to Reddit and other platforms via API. Trigger phrases: "social media post", "tweet", "LinkedIn post", "Instagram caption", "TikTok script", "social content", "social media copy", "carousel", "thread", "social media strategy", "repurpose content", "hashtag strategy", "post to reddit", "publish on social", "post on reddit", "share on social media".

日本語の概要は準備中です。原文の説明を表示しています。

Write viral Twitter/X threads and Reddit posts with proven structures, hooks, and engagement tactics. Includes templates for story threads, listicle threads, contrarian takes, tutorials, and case studies. Can post directly to Reddit. Trigger phrases: "write a thread", "Twitter thread", "X thread", "viral thread", "thread writer", "tweetstorm", "thread template", "thread about", "turn this into a thread", "reddit post", "write a reddit post".

日本語の概要は準備中です。原文の説明を表示しています。

Mileage earning rates by airline and booking class via wheretocredit.com. Redeemable and qualifying miles across 50+ programs. Use when deciding where to credit a flight or comparing earning rates.

日本語の概要は準備中です。原文の説明を表示しています。